Pressing for a final rush of health care enrollees, President Barack Obama said Tuesday that about 4 million people have signed up for health insurance through federal or state marketplaces set up under his health care law.
Pressing for a final rush of health care enrollees, President Barack Obama said Tuesday that about 4 million people have signed up for health insurance through federal or state marketplaces set up under his health care law.
But with a key deadline approaching fast, he urged some of his most steadfast backers to help sign up millions more by then.
"We've only got a few weeks left. March 31st, that's the last call," Obama said, explaining that anyone not signed up by that date will have to wait until open enrollment begins anew in the fall. In the meantime, they risk being fined for not having coverage.
The White House has set an unofficial goal of 7 million enrollees by the end of March.
Read the full story here: http://abcn.ws/1k98zEA
Source: ABC News
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More